About Division of High-Consequence Pathogens and Pathology

At a glance

The Division of High-Consequence Pathogens and Pathology (DHCPP) protects people from serious and unusual infectious diseases by detecting threats, investigating outbreaks, and developing better ways to diagnose, prevent, and control disease.

Three health workers in personal protective equipment

Our mission

High-consequence pathogens cause serious and deadly infections and pose a significant threat to domestic and global security. Many are contagious, and most spread from animals to people. Some can be used as bioterrorism agents. DHCPP prepares for and helps communities respond to U.S. and global health security threats associated with high-consequence pathogens.

Our work

Fulfilling our mission

DHCPP helps protect Americans around the world from anthrax, Creutzfeldt–Jakob disease, Ebola, hantavirus, leprosy, Nipah, rabies, smallpox, viral hemorrhagic fevers, and other serious diseases.

To protect people from infectious disease threats, we work with partners in the United States and around the world to turn science into public health action, which includes:

  • Preparing for and responding to outbreaks caused by these diseases
  • Detecting and diagnosing these infectious diseases.
  • Identifying previously unrecognized infectious diseases
  • Monitoring these diseases
  • Improving medical countermeasures that diagnose, prevent, and treat diseases

Unique expertise

Our staff have specialized expertise and experience in epidemiology, high-containment laboratory testing and research, pathology, veterinary and animal ecology, and some of the world's rarest but deadliest diseases. This expertise allows DHCPP staff to:

  • Analyze disease trends and epidemiologic data to predict and contain emerging infectious diseases.
  • Create tests and novel methods to diagnose diseases and develop medical countermeasures to mitigate and prevent high-consequence disease threats.
  • Build and continually improve laboratories designed to work with high-consequence pathogens.
  • Discover, detect, and characterize some of the world's most deadly and disabling diseases.
  • Provide clinical consultation and technical assistance to health departments and clinicians.
  • Build partnerships in the United States and around the world to meet current and future public health challenges.

Protect. Modernize. Connect: DHCPP's long-standing relationships and expertise put us on the front lines of responding to, preparing for, and improving readiness to manage known and emerging threats from high-consequence pathogens.

Leadership bio

Portrait of Brendan Jackson
Fernando Torres-Vélez, DVM, PhD
Division of High-Consequence Pathogens and Pathology
CAPT Brendan Jackson, MD, MPH (USPHS), Acting Director

CAPT Brendan Jackson, MD, MPH (USPHS), is the acting director of the Division of High-Consequence Pathogens and Pathology in CDC’s National Center for Emerging and Zoonotic Infectious Diseases.

Content Source
National Center for Emerging and Zoonotic Infectious Diseases (NCEZID)
About this page
Published: May 15, 2024
Updated: November 18, 2026

This page was last updated on this date. Updates may include minor edits, image changes, or other modifications to page content.

Reviewed: November 18, 2026

The information on this page was last reviewed by subject matter experts to ensure accuracy.